Northpond and Deerfield have co-led a $75m series C round for Encodia, seemingly the first publicly disclosed funding for the WashU spinout.

Nan Fung Life Sciences’ Pivotal BioVenture Partners co-led a $35m extension to the cancer therapy developer’s series A round.

Northpond and Deerfield have co-led a $75m series C round for protein analysis system developer Encodia that included GV and Nan Fung Life Sciences.

Landos has filed to go public after a phase 2 trial of its Virginia Tech-invented IBD treatment produced favourable results this month.

The firm's LAV Fund VI and LAV Fund VI Opportunities funds have been supplied by $100m from Los Angeles County Employees Retirement Association.

Baupost Group has led another round for Wren Therapeutics, a spinout of Cambridge and Lund universities.

Heritage Group has added $317m having previously raised $220m for its second fund four years ago.

The virtual care app developer has added $8m of additional capital to its series B round backed by Northwell Ventures and UH Ventures.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

The medical equipment maker is set to pay as much as $925m to buy its portfolio company that will enable Novo, Merck & Co and Samsung to exit.